Financial Performance - The company's revenue for Q3 2021 reached ¥503,293,812.78, representing a year-over-year increase of 38.57%[8] - Net profit attributable to shareholders was ¥79,181,669.88, up 72.20% compared to the same period last year[8] - The net profit after deducting non-recurring gains and losses was ¥77,424,610.62, reflecting a 66.99% increase year-over-year[8] - Total operating revenue for Q3 2021 reached ¥1,274,585,137.05, a significant increase of 47.6% compared to ¥863,722,830.58 in Q3 2020[23] - Net profit for Q3 2021 was ¥225,095,776.79, representing a 104.5% increase from ¥109,948,307.06 in Q3 2020[24] - Earnings per share for Q3 2021 were ¥0.5032, compared to ¥0.2634 in Q3 2020, reflecting a growth of 91.1%[25] - The total comprehensive income for Q3 2021 was ¥225,095,776.79, compared to ¥109,948,307.06 in Q3 2020, indicating strong growth in overall profitability[25] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,983,807,135.22, a 34.81% increase from the end of the previous year[8] - Total assets as of September 30, 2021, amounted to ¥1,983,807,135.22, an increase of 34.7% from ¥1,471,513,584.46 at the end of 2020[21] - Total liabilities increased to ¥367,427,290.45, up 64.0% from ¥224,131,297.98 at the end of 2020[21] - The company's equity attributable to shareholders reached ¥1,538,448,316.65, a rise of 26.0% from ¥1,222,264,042.61 at the end of 2020[21] - Total liabilities rose to ¥292,624,792.11 from ¥224,131,297.98, representing an increase of approximately 30.6%[32] Cash Flow - Cash flow from operating activities showed a net outflow of ¥52,558,365.95, a significant decline of 408.71% compared to the previous year[12] - Cash inflow from operating activities increased to ¥1,008,192,482.15, up from ¥789,891,349.66, representing a growth of approximately 27.8%[27] - Cash outflow from operating activities rose to ¥1,060,750,848.10, compared to ¥772,866,278.35, indicating an increase of about 37.2%[27] - Cash inflow from investment activities decreased to ¥193,242,445.52 from ¥471,333,090.71, reflecting a drop of approximately 59.0%[28] - Net cash flow from investment activities was -¥117,042,737.52, a significant decline from a positive ¥17,479,692.19 in the prior period[28] - Cash inflow from financing activities increased to ¥167,627,777.90, up from ¥1,575,000.00, marking a substantial rise of over 10,500%[28] - Net cash flow from financing activities was positive at ¥165,579,634.56, compared to a negative -¥93,474,970.14 in the previous period[28] - The ending cash and cash equivalents balance was ¥348,177,024.79, a decrease from ¥197,010,946.59, indicating a reduction of approximately 43.5%[28] Shareholder Information - Total number of common shareholders at the end of the reporting period is 27,634[15] - Shanghai Lanwei Investment Co., Ltd. holds 37.34% of shares, totaling 149,554,017 shares[15] - The top ten shareholders collectively hold significant stakes, with the largest shareholder owning over 37%[15] - The total number of unrestricted shares held by the top ten unrestricted shareholders is 1,000,000[15] - The company has a total of 352,455,000 restricted shares, with no shares released during the reporting period[17] - The company plans to release 4,806,200 shares from the initial public offering on September 13, 2022[17] Research and Development - Research and development expenses increased by 45.06% to ¥22,993,309.05, indicating a strong commitment to innovation[12] - Research and development expenses for Q3 2021 were ¥22,993,309.05, an increase of 45.0% compared to ¥15,851,160.07 in Q3 2020[24] - The company has ongoing research and development efforts, although specific new products or technologies were not detailed in the provided content[15] Other Financial Information - The weighted average return on equity was 5.82%, an increase of 51.17% compared to the same period last year[8] - The company reported a financial expense of ¥787,507.68, compared to a financial income of ¥342,952.76 in the previous year[24] - The company adopted the new leasing standards starting January 1, 2021, impacting financial statement disclosures[34] - The third quarter report for 2021 has not been audited[35]
兰卫医学(301060) - 2021 Q3 - 季度财报